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Abstract
Background:  Respiratory  infections  are  known  to  exacerbate  wheezing  in  many
asthmatic  patients.  We  aimed  to  use  molecular  methods  for  the  fast  detection  of
Mycoplasma  pneumoniae, Chlamydia  pneumoniae  and  Legionella  pneumophila  in
respiratory  specimens  from  asthmatic  patients  in  Kuwait.
Methods:  We  used  uniplex  PCR  assays  to  detect  the  three  atypical  bacteria  in  clinical
specimens  from  235  asthmatic  and  non-asthmatic  patients  in  Kuwait.  A regression
analysis  was  used  to  identify  the  risk  factors  related  to  the  bacterial  type.  Group
comparisons  for  similarity  were  conducted  and  correlation  coefﬁcients  were  calcu-
lated  using  SPSS  statistical  software.
Results:  The  detection  limits  using  uniplex  PCR  for  C.  pneumoniae, L.  pneumophila
and  M.  pneumoniae  were  approximately  1  pg,  2.4  fg  and  12  pg  of  DNA,  respectively.
M.  pneumoniae  PCR  positivity  was  more  common  in  asthmatic  patients  (15%)  than  in
non-asthmatic  subjects  (9%)  (P  <  0.05).  A  marked  difference  was  observed  between
patients  with  acute  asthma  exacerbation  (11%)  and  patients  with  chronic  (stable)
asthma  (7%)  among  Kuwaiti  patients;  these  percentages  were  16%  for  non-Kuwaiti
acute  asthma  patients  and  14%  for  non-Kuwaiti  chronic  asthma  patients  (P  <  0.201).
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PCR  detection  of  atypical  bacteria  in  asthma  patients  
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sthma  is  a  prevalent  disease  with  marked  effects
n quality  of  life  and  with  economic  and  soci-
tal burden.  However,  the  cause  of  asthma  and
ts pathophysiology  are  not  completely  understood.
ecently, the  possibility  that  chronic  infection  may
lay a  role  has  been  suggested  [1,2].  The  possible
ole  of  atypical  bacterial  infections  in  the  patho-
enesis  of  asthma  is  an  area  of  intense  discussion.
here is  an  increasing  body  of  literature  regarding
he association  between  the  atypical  bacteria  C.
neumoniae  and  M.  pneumoniae  and  asthma  patho-
enesis [3].
Respiratory  infections  are  known  to  precipitate
heezing in  many  asthmatic  patients  and  may
e involved  in  the  etiopathogenesis  of  asthma.
ecently, studies  have  investigated  the  associations
f infections  with  the  atypical  bacteria  M.  pneu-
oniae,  C.  pneumoniae  and  L.  pneumonia  with
oth acute  exacerbation  and  chronic  asthma  [4].
vidence from  human  studies  links  both  M.  pneu-
oniae  and  C.  pneumoniae  to  new-onset  wheezing,
xacerbations of  prevalent  asthma  and  long-term
ecreases in  lung  function,  suggesting  that  these
rganisms  can  play  an  important  role  in  the  nat-
ral history  of  asthma  [5].  One  published  case
eport  describes  a  patient  in  whom  a  previous  acute
ycoplasma  respiratory  infection  led  to  the  initial
nset of  bronchial  asthma  [6].
Asthma  pathogenesis  appears  to  be  the  result
f a  complex  combination  of  genetic  and  envi-
onmental inﬂuences.  There  is  evidence  that  M.
neumoniae  and  C.  pneumoniae  play  roles  in
romoting  airway  inﬂammation  that  could  con-
ribute  to  the  onset  and  clinical  course  of  asthma
6]. M.  pneumoniae  has  been  associated  with
ospitalization  for  the  acute  exacerbation  of
ronchial  asthma  [1,7].  Asthmatic  patients  fre-
uently develop  wheezing  after  respiratory  tract
nfections  [8].  Gil  et  al.  found  that  M.  pneumo-
iae colonizes  a  greater  percentage  of  patients  with
sthma than  controls  and  may  induce  wheezing
8]. Sutherland  et  al.  reported  that  the  atypi-
al bacteria  M.  pneumoniae  and  C.  pneumoniae
a
r
c135
rrelation  between  asthma  severity  and  PCR  positivity  for
sults  for  C.  pneumoniae  and  L.  pneumoniae  were  found
t.
is  study  suggest  that  infection  with  M.  pneumoniae  may
ion  of  asthma  symptoms  and  could  possibly  be  a  factor
ziz  University  for  Health  Sciences.  Published  by  Elsevier
re  present  in  the  lower  airways  of  approximately
0% of  asthmatics  [6].  Additionally,  Allegra  et  al.
eported seroconversion  to  C.  pneumoniae  in  asth-
atic patents  [9].
Asthma  is  increasingly  considered  an  inﬂamma-
ory disease  and  is  treated  with  inhaled  and/or
ystemic corticosteroids.  Cases  of  unusual  pneumo-
ias due  to  L.  pneumonia  associated  with  high  doses
f oral  steroids  have  been  reported  [10].
The etiologic  diagnosis  of  these  infections
emains difﬁcult.  This  difﬁculty  is  primarily  due
o the  absence  of  characteristic  clinical  ﬁndings
nd the  lack  of  available  detection  methods  [11].
. pneumoniae, M.  pneumoniae  and  L.  pneu-
ophila are  responsible  for  community-acquired
espiratory  tract  infections,  in  particular,  atypi-
al pneumonia  [8,10,12]. M.  pneumoniae  infections
re acute  and  may  require  hospitalization,  whereas
. pneumoniae  infections,  which  are  frequently
symptomatic,  can  be  responsible  for  long-lasting
iseases that  are  more  severe  in  elderly  patients
13]. For  a speciﬁc  treatment  to  be  administered,
 rapid  diagnosis  must  be  obtained.  The  isolation
f M.  pneumoniae  or  C.  pneumoniae  requires  6—21
ays and  is  often  negative.  Rapid  laboratory  tests
uch as  antigen  detection  or  hybridization  are  of
imited sensitivity,  and  serology  is  often  inconclu-
ive; thus,  gene  ampliﬁcation  that  permits  a  rapid
nd sensitive  diagnosis  is  the  method  of  choice
14,15]. When  the  presence  of  different  agents  is
eing investigated,  a multiplex  polymerase  chain
eaction (PCR)  is  of  interest  [16,17].  We  have
evised  a method  for  the  detection  of  C.  pneu-
oniae and  M.  pneumoniae  that  can  be  applied
o clinical  samples  collected  from  in-patients  with
espiratory  symptoms  [18,19].
The  detection  of  M.  pneumoniae, C.  pneumoniae
nd L.  pneumophila  in  children  with  respiratory
ymptoms is  usually  considered  evidence  of  an
cute infection.  The  current  methods  for  the  iden-
iﬁcation  of  these  agents  include  cell  culture,  rapid
ntigen detection  assays,  serology  (indirectly)  and,
ecently, PCR  [20].
Although  no  rapid  method  for  the  microbiologi-
al diagnosis  of  atypical  pneumonia  (AP)  is  available
J.A.  Qasem  et  al.
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for  routine  use,  the  availability  of  such  a  test  could
result in  less  antibiotic  therapy  and  more  precisely
tailored  antibiotic  therapies,  resulting  in  reduced
costs,  fewer  side  effects  and  a  reduction  in  the
emergence  of  resistance  [21].
The  objective  of  this  study  was  to  determine
the prevalence  rates  of  the  atypical  bacteria  C.
pneumoniae, L.  pneumophila  and  M.  pneumoniae
in asthmatic  patients  in  Kuwait  using  a  uniplex  poly-
merase chain  reaction  method  (uniplex  PCR).
Materials and methods
DNA extraction method
Throat  swab  samples  were  obtained  using  Dacron
swabs  and  were  placed  in  sterile  tubes  containing
2 ml  of  Tris-EDTA  (TE)  solution  (2  M  Tris  HCL  +  0.5  M
EDTA). These  samples  were  transported  quickly  to
the laboratory  for  DNA  extraction.  A  simple  and
sensitive  method  for  DNA  extraction  similar  to  the
method previously  described  by  us  for  M.  pneumo-
niae  and  L.  pneumoniae  was  used  [18,19].
PCR identiﬁcation
We  used  three  separate  assays,  with  one  set  of
primers  (uniplex)  for  each  bacterial  genus  and
species  and  for  the  detection  of  bacterial  DNA
(Table 1).
Uniplex primers
To  detect  M.  pneumoniae, the  P1-178  and  P1-331
primers,  which  amplify  a  153  bp  fragment  (see
Table 1)  of  the  cytadhesin  gene  [22],  were  used.  To
detect C.  pneumoniae,  the  CpA  and  CpB  primers,
which amplify  a  463  bp  fragment  of  the  conserved
16 sRNA  gene  [23],  were  used.  To  detect  L.  pneu-
mophila,  LmipL  and  LmipR,  which  amplify  a  649  bp
fragment of  the  mip  (macrophage  infectivity  poten-
tiator),  were  used  [24].
All  uniplex  ampliﬁcation  reactions  were  per-
formed in  a  volume  of  25  l  and  contained  5  ml  of
extracted  DNA,  10  mM  Tris—HCl  (pH  9),  50  mM  KCl,
0.01% gelatin,  200  mM  deoxynucleotide  triphos-
phates, 1.0  U  Taq  polymerase  and  primers  and  MgCl2
at  the  concentrations  indicated  in  Table  1.
The M.  pneumoniae  PCR  cycles  included  dena-
turation for  4  min  at  94 ◦C  followed  by  34  cycles
of ampliﬁcation;  each  cycle  consisted  of  denatur-
ation for  1  min  at  94 ◦C,  annealing  for  2  min  at  55 ◦C
and extension  for  3 min  at  72 ◦C.  A  ﬁnal  extension
step was  performed  for  5  min  at  72 ◦C.  For  the  C. T
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ACR  detection  of  atypical  bacteria  in  asthma  patien
neumonia  ampliﬁcation  using  CpnA  and  CpnB
1 M  each),  the  PCR  cycles  were  conducted  as
ollows:  incubation  for  10  min  at  95 ◦C,  followed
y 40  cycles  of  94 ◦C,  55 ◦C  and  72 ◦C  for  1 min
ach. A  ﬁnal  extension  at  72 ◦C  for  10  min  was  also
erformed.  For  L.  pneumophila,  the  target  DNA
equence  was  ampliﬁed  using  the  LmipL  and  LmipR
rimers,  both  at  0.5  M.  The  PCR  cycles  were  con-
ucted  as  follows:  denaturation  for  4  min  at  94 ◦C,
ollowed by  35  cycles  of  denaturation  for  1  min  at
4 ◦C,  annealing  for  1  min  at  50 ◦C  and  extension  for
 min  at  72 ◦C.  A  ﬁnal  incubation  for  10  min  at  72 ◦C
as also  performed.
The sensitivity  of  the  PCR,  measured  based
n ethidium  bromide  staining  of  the  ampliﬁcation
roducts, was  estimated  with  10-fold  dilutions  of
 standard  amount  of  DNA  for  each  of  the  three
rganisms.
The PCR  products  were  detected  and  analyzed
y standard  electrophoresis  on  agarose  gels  (12  g/l)
n 89  mM  Tris/89  mM  sodium  borate/200  mM  EDTA
uffer,  pH  8,  and  were  stained  with  0.5  mg/ml
thidium bromide.  A  100-bp  DNA  ladder  was  used
s a  molecular  marker.
ist of reference bacterial species and
trains
ositive  control  DNA  samples  were  obtained  from
he National  Culture  Type  Collection  (NCTC)  and
he American  Type  Culture  Collection  (ATCC)  and
ncluded L.  pneumophila  NCTC  11192,  M.  pneumo-
iae NCTC  10119  FH  and  C.  pneumonia  ATCC  1356.
Negative  controls  (sterile  water  and  DNA  from
espiratory pathogens  such  as  Staphylococcus
ureus (ATCC  25923),  Pseudomonas  aeruginosa
ATCC 27853),  Haemophilus  inﬂuenzae  (ATCC
9766), E.  coli  (ATCC  35150),  Bacillus  cereus  (ATCC
1778) and  Enterococcus  faecalis  (ATCC  29212))
ere also  prepared  and  ampliﬁed  under  conditions
imilar to  those  for  the  clinical  specimens  described
arlier.
linical specimen collection
he  study  included  235  clinical  sputum  specimens
ollected from  74  acute  asthmatic  patients,  117
hronic  asthmatic  patients  and  45  non-asthmatic
control) patients  at  Al-Sabah  Hospital,  Kuwait,  who
isited the  emergency  department  or  were  admit-
ed to  the  ward.  This  study  was  a  case—control
tudy. The  sample  size  was  determined  using  an  ˛-
evel of  5%  and  a  power  of  80%  (ˇ  =  20%)  using  the
pi Info  program.
t
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A  total  of  190  clinical  samples  from  patients  diag-
osed with  bronchial  asthma  on  the  basis  of  clinical
ymptoms,  signs  and  pulmonary  function  were  stud-
ed.
We studied  190  patients  with  bronchial  asthma
109 males  with  a mean  age  of  43.7  years  and  81
emales with  a  mean  age  of  34  years)  and  45  sub-
ects without  asthma  (26  males  with  a  mean  age  of
5.5 years  and  19  females  with  a  mean  age  of  37
ears) who  served  as  controls.
Out of  the  190  patients  with  bronchial  asthma,
4 had  acute  exacerbations  of  asthma,  and  116  had
hronic or  stable  asthma.  The  diagnosis,  drug  pre-
criptions  and  patient  history  were  obtained  from
he patient  ﬁles  and  used  to  conﬁrm  the  asthma
ases.
The exclusion  criteria  were  as  follows:  sus-
ected viral  infections;  allergic  rhinitis  or  allergic
inusitis;  smoking;  chronic  obstructive  pulmonary
isease  (COPD);  a  radiological  diagnosis  of  pneu-
onia, cardiac  asthma  or  pulmonary  eosinophilia,
ncluding allergic  bronchopulmonary  aspergillosis
ABPA); antibiotic  use  within  the  previous  48  h;  and
atients requiring  intensive  care.
Patients  were  considered  to  have  acute  asthma
f their  daily  activities  were  severely  restricted  by
requent episodes  of  moderate  to  severe  asthma
ymptoms  (moderate  to  severe  attacks)  that  could
e controlled  only  by  the  regular  use  of  high  doses
f inhaled  corticosteroids.
Chronic  asthma  included  a wide  range  of clinical
ndings  between  mild  and  severe  asthma.  Patients
ith  chronic  asthma  showed  chronic  mild  to  moder-
te symptoms  that  frequently  interfered  with  daily
ctivities and  sleep  and  required  the  regular  use  of
anagers and  anti-inﬂammatory  agents.
thical approval
he  study  was  approved  by  the  Ethical  Commit-
ee of  the  Ministry  of  Health  and  the  College
f Health  Sciences,  Kuwait.  This  work  was  per-
ormed  in  accordance  with  the  code  of  ethics  of  the
orld Medical  Association  (Declaration  of  Helsinki
or experiments  involving  humans).  Each  subject
as interviewed,  and  a signed  informed  consent
as obtained.  Age,  gender  and  nationality  were
ecorded.
tatistical analysis
sthmatic  patients  were  compared  with  regard  to
he presence  or  absence  of  Mycoplasma, Chlamy-
ia or  Legionella  using  the  2 test  [25].  In  the
tatistical analysis,  the  predictor  or  explanatory
ariables included  asthma  type  and  positive  PCR
138  J.A.  Qasem  et  al.
Table  2  Summery  of  PCR  results  for  Kuwaiti  asthmatic  patients  and  control  and  the  prevalence  of  the  three
atypical  bacteria.
Organisms  Patients
Acute  asthma
patients
n  =  43  (KW)
n  =  31  (Non-KW)
Chronic  asthma
patients
n =  70  (KW)
n  =  46  (non-KW)l
Control
n =  34  (KW)
n  =  11  (non-KW)
Total
n =  147  (KW)
n =  88  (Non-KW)
M F Total M F Total M  F  Total
Mycoplasma  pneumonia
Kuwaitis  4/30  1/13  11.2%  5—38  0—32  7.1%  1/19  0/15  3%  7.5%
Non  Kuwaitis  4/16  1/15  16%  2/25  3/21  13.9%  1/7  0/4  9.1  12.5%
Chlamydia  pneumonia
Kuwaitis  2/30  1/13  7%  3/38  0/32  4.3%  1/19  0/15  3%  4.8%
Non  Kuwaitis  0/16  2/15  6.5%  1/25  0/21  5.9%  0/7  0/4  0%  3.4%
Legionella  pneumonia
Kuwaitis  1/30  0/13  2.3%  1/38  0/32  1.4%  0/19  0/15  0  1.4%
Non  Kuwaitis  1/16  0/15  3.2%  1/25  0/21  2.8%  0/19  0/4  0  2.3%
Total
Kuwaitis  20.9%  12.9%  5.9%  15%
Non  Kuwaitis  25.8%  15.2%  9.1%  18.2%
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wresults  for  atypical  bacteria  (Mycoplasma, Chlamy-
dia and  Legionella). The  patients  were  segregated
into three  groups:  acute  asthmatic,  chronic  asth-
matic and  non-asthmatic  (control)  subjects.  These
groups were  cross  tabulated  with  the  prevalence
rates of  the  three  bacterial  types  to  distinguish  the
severity of  the  diseases  vs  the  biological  effect.
Other groups  (nationality  and  gender)  were  also
compared  with  respect  to  the  bacterial  prevalence
rates using  the  2 test.  All  data  were  statistically
analyzed with  SPSS  version  10.1  (Statistical  Package
for Social  Studies,  Chicago,  Illinois,  USA).  Statisti-
cal signiﬁcance  was  deﬁned  as  a  P-value  less  than
0.05 [26].
Results
To  test  the  speciﬁcity  of  the  ampliﬁed  products,
control experiments  were  performed  under  the
same conditions  with  DNA  from  various  microorgan-
isms that  are  likely  to  be  found  in  human  respiratory
tract specimens  and  from  other  microorganisms
that are  not  respiratory  pathogens.  The  ampliﬁca-
tion  of  463  bp,  153  bp  and  649  bp  DNA  fragments
was not  observed  for  genomic  DNA  from  any  of
these  organisms  (data  not  shown).  PCR  ampliﬁca-
tion was  able  to  detect  the  DNA  of  C.  pneumonia,
L. pneumophila  and  M.  pneumoniae, yielding  bands
of the  correct  sizes  for  each  species.  The  limits  of
0
a
r
petection  for  the  PCRs  were  approximately  1  pg,  2.4
g and  12  pg  of  DNA,  respectively.
The  results  for  Mycoplasma  pneumoniae  are  pre-
ented in  Table  2.  The  PCR  results  were  found  to  be
ositive for  10  of  the  113  Kuwaiti  chronic  and  acute
sthmatic  patients  (8.8%)  and  for  1  of  the  34  Kuwaiti
ontrols  (3%).  Five  of  the  43  patients  (11.2%)  with
cute exacerbation  and  5 of  the  70  (7.1%)  chronic
sthmatics  were  found  to  be  PCR  positive.  For  non-
uwaiti patients,  Mycoplasma  was  detected  in  10  of
he 113  acute  and  chronic  patients,  equivalent  to  a
ercentage of  12.9%  (Table  2).  The  difference  was
ot statistically  signiﬁcant  (P  <  0.239)  (Table  3).
The C.  pneumoniae  PCR  was  positive  for  7%
nd 4.3%  of  Kuwaiti  acute  and  chronic  asthmatic
atients, respectively,  with  a total  of  5.3%  for  all
uwaiti asthmatic  patients  (n  =  113)  (Table  2).  In
omparison,  the  Kuwaiti  control  samples  had  a
ositivity rate  of  2.9%  (Table  2).  In  non-Kuwaiti
atients, C.  pneumoniae  was  detected  in  6.5%  and
.9% of  acute  and  chronic  patients,  respectively,
ith a prevalence  of  3.9%  for  non-Kuwaiti  acute
nd chronic  asthmatics  when  considered  together
n =  77).  In  contrast,  the  prevalence  was  0%  for  non-
uwaiti controls  (Table  2).  However,  this  difference
as not  statistically  signiﬁcant  (P  <  0.411).
L. pneumophila  was  detected  in  2.3%,  1.4%  and% of  acute,  chronic  and  control  Kuwaiti  samples
nd in  3.2%,  2.8%  and  0%  of  non-Kuwaiti  samples,
espectively (Table  2),  equivalent  to  an  overall
revalence of  1.7%  (2  of  113  patients)  for  Kuwaiti
PCR  detection  of  atypical  bacteria  in  asthma  patients  
Ta
bl
e  
3  
St
at
is
ti
ca
l  a
na
ly
si
s  
be
tw
ee
n  
th
e  
va
ri
ab
le
s  
us
in
g  
Pe
ar
so
n  
Ch
i-
sq
ua
re
 
—

2
, 
co
m
pu
te
d 
at
 
2 
×
2  
ta
bl
e,
 
df
 
=  
1.
Se
ve
ri
ty
 
of
 
th
e  
di
se
as
e
N
at
io
na
lit
y
Se
x
Ch
ro
ni
c
n  
= 
11
6
Ac
ut
e
n  
=  
74
Co
nt
ro
l
n  
=  
45
P
KW n  
=  
14
7
N
on
 
KW
n  
= 
88
P
M
al
es
n  
=  
13
5
Fe
m
al
es
n  
= 
10
0
P
M
yc
op
la
sm
a  
pn
eu
m
on
ia
8.
6  
13
.5
 
4.
4  
0.
23
9  
7.
5  
12
.5
 
0.
20
1  
12
.6
 
5
0.
04
8
Ch
la
m
yd
ia
 
pn
eu
m
on
ia
e
3.
4  
6.
8  
2.
2  
0.
41
1  
4.
8  
3.
4  
0.
61
9  
5.
2  
3
0.
41
2
Le
gi
on
el
la
 
pn
eu
m
op
hi
la
1.
7 
2.
7 
0 
0.
54
3 
1.
4 
2.
3 
0.
60
1 
3 
0 
0.
08
3
p
p
p
a
a
d
g
t
d
n
(
o
v
n
(
f
A
t
w
(
D
I
w
(
t
(
t
f
e
T
b
t
t
g
r
r
p
H
o
e
t
a
s
n
w
[
p
a
r
t139
atients  and  2.6%  (2  of  77  patients)  for  non-Kuwaiti
atients. However,  a positive  PCR  result  for  L.
neumophila  was  not  signiﬁcantly  correlated  with
sthma severity  (P  <  0.543)  (Table  3).
As shown  in  Table  3,  the  comparison  of  the
sthma severity  with  the  types  of  bacteria  detected
id not  reveal  any  signiﬁcant  difference  between
roups (P  <  0.239).  In  regard  to  the  nationality  of
he patients  (Kuwaitis  vs  non-Kuwaitis),  no  marked
ifferences  were  observed  between  Kuwaitis  and
on-Kuwaitis  with  respect  to  the  bacterial  type
P <  0.201).
However,  a  comparison  of  the  prevalence  rates
f the  bacterial  species  between  genders  (males
s females)  showed  different  results.  M. pneumo-
iae was  more  prevalent  in  male  asthmatic  patients
12.6%)  than  female  asthmatic  patients  (5%),  a  dif-
erence that  was  signiﬁcant  (P  <  0.048)  (Table  3).
 regression  analysis  showed  that  the  best  predic-
or, i.e.,  the  species  that  had  the  greatest  effect,
as M.  pneumoniae, with  an  odds  ratio  of  1.582
P <  0.208)  (Table  3).
iscussion
n  our  study,  positive  PCR  results  for  M.  pneumoniae
ere more  common  for  the  asthmatic  non-Kuwaiti
13%) and  Kuwaiti  (9%)  asthmatic  patients  than  for
he non-asthmatic  Kuwaiti  (3%)  and  non-Kuwaiti
9.1%) groups.  A  logistic  regression  analysis  showed
hat M.  pneumoniae  was  the  greatest  risk  factor
or asthma  (odds  ratio  1.7)  but  had  no  signiﬁcant
ffect on  asthma  severity  (P  < 0.17  —  CI  0.6—12.4).
his result  may  indicate  that  acute  asthma  exacer-
ations  in  asthmatics  may  be  more  closely  related
o Mycoplasma  infection  than  to  infections  with
he other  microorganisms  even  though  the  control
roup had  the  same  odds  ratio.  These  results  cor-
oborate  the  earlier  ﬁndings  that  there  is  a  higher
ate of  M.  pneumoniae  detection  among  asthmatic
atients  than  among  non-asthmatic  patients  [27].
owever, in  our  study,  this  marked  difference  was
bserved  only  in  Kuwaiti  patients  with  acute  asthma
xacerbation  (5/43  vs  5/70  for  acute  exacerba-
ion and  chronic  asthma,  respectively).  There  was
 positive  percentage  distribution  between  asthma
everity  and  PCR  positivity,  but  no  statistical  sig-
iﬁcance was  observed.  This  ﬁnding  is  consistent
ith the  results  of  a previous  study  by  Kraft  et  al.
27], who  reported  a higher  detection  rate  of  M.
neumoniae  in  the  airways  of  adults  with  chronic
sthma.  Our  ﬁndings  also  support  these  authors’
ecommendation to  evaluate  M.  pneumoniae  infec-
ion and,  in  selected  cases,  to  administer  empirical
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antibiotic  treatment  to  patients  with  persistent
severe asthma  that  is  poorly  controlled  despite  the
use of  conventional  anti-inﬂammatory  asthma  ther-
apy [27].
In contrast  to  studies  that  have  suggested  a link
between  C.  pneumoniae  infection  and  the  exac-
erbation  of  asthma  as  well  as  disease  initiation
[28], we  did  not  ﬁnd  any  statistically  signiﬁcant
difference in  the  rate  of  C.  pneumoniae  detection
by PCR  between  asthmatics  and  non-asthmatics
(4.3% vs  4.8%),  and  a  large  difference  was  observed
between patients  with  acute  exacerbation  and
chronic  asthma  (7%  vs  4.8%).  The  ﬁndings  on  this
issue are  not  consistent.  Although  M.  pneumoniae
seems to  be  more  important  for  asthma  pathogen-
esis and  exacerbation  than  C.  pneumonia  in  some
studies,  the  role  of  C.  pneumoniae  was  found  to
be more  signiﬁcant  in  other  studies.  These  results
are similar  to  those  reported  by  Martin  et  al.,  who
found that  the  throat  swabs  from  7  of  the  55  (12.8%)
asthmatic  patients  were  positive  for  C.  pneumoniae
according to  the  PCR  [29].
Only a  few  studies  have  reported  an  association
between asthma  and  L.  pneumophila.  Lieberman
et al.  found  a  higher  seroprevalence  in  asthmatic
children than  in  healthy  controls  [30].  In  our  study,
a higher  rate  of  L.  pneumophila  PCR  positivity  was
observed in  the  Kuwaiti  asthmatic  group  (2%  vs  0%),
but there  was  no  correlation  between  asthma  and
PCR positivity  for  L.  pneumophila  (P  <  0.54).  One  of
the 43  patients  who  were  PCR  positive  had  acute
exacerbation, and  1  had  stable  asthma.  Legionella
infections, which  cause  intracellular  infections  sim-
ilar to  those  of  potential  initiators  or  exacerbators
of asthma  such  as  viruses  and  C.  pneumoniae, may
also be  associated  with  asthma  symptoms.  In  our
study, we  did  not  use  the  ‘‘gold  standard’’  diagno-
sis method  for  Legionella  infections,  namely,  the
culture of  the  microorganism,  so  this  possibility
remains to  be  investigated.
In  summary,  we  found  that  infection  with  M.
pneumoniae  is  related  to  the  exacerbation  of
asthma  symptoms  and  is  weakly  correlated  with  the
disease severity.
A regression  analysis  showed  that  the  best  pre-
dictor,  i.e.,  the  bacterial  species  that  has  the
greatest  effect,  was  M.  pneumoniae,  with  an  odds
ratio of  1.582  (P  <  0.208).  Thus,  there  was  a  very
small signiﬁcant  effect  on  the  exacerbation  of
asthma symptoms.
This ﬁnding,  namely,  the  correlation  of  PCR  pos-
itivity with  asthma  severity,  may  be  considered  as
evidence for  the  causality  of  this  association.  The
use of  antibiotics  to  treat  infections  with  atypi-
cal bacteria  could  play  a  role  in  the  management
of acute  asthma  attacks.  The  possibility  of  M.
[J.A.  Qasem  et  al.
neumoniae  infection  should  be  considered  in  cases
f acute  and  severe  exacerbations  and  in  difﬁcult-
o-treat  asthmatics.  Empirical  antibiotic  treatment
argeting  this  pathogen  should  be  administered  in
elect cases  only  [28].  Although  researchers  are
ncouraged  by  the  clinical  and  experimental  suc-
ess with  antibiotic  therapy  in  a  subset  of  asthma
atients,  long-term  antibiotic  treatment  for  asthma
ay be  controversial  [2].
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